OTCQB:EMHTF - Post by User
Post by
goinfishnon Aug 14, 2018 4:44pm
81 Views
Post# 28459932
Abattis Completes Sale of Northern Vine Interest
Abattis Completes Sale of Northern Vine Interest Abattis Completes Sale of Northern Vine Interest
VANCOUVER, British Columbia, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE: ATT / OTC: ATTBF) is pleased to announce that it has completed the sale (the “Sale”) of its 35% interest in Northern Vine Canada Inc. (“Northern Vine”) to Emerald Health Therapeutics, Inc. (TSXV:EMH / OTCQX:EMHTF) (“Emerald”) in exchange for $2 million in cash and $4 million in common shares of Emerald, 50% of which are free trading and 50% of which may be sold in 30 days.